Month: October 2022
-
Evaluating Treatment Options for Peripheral Artery Disease
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
-
Study Uncovers Role of Mitochondrial Energy Production in Dopaminergic Neurons
Northwestern Medicine investigators have discovered that dopaminergic neurons in the substantia nigra utilize a specific ion channel to control energy production and meet bioenergetic need, according to a recent study.
-
Kimberly Querrey, Louis Simpson Trust Give $100 Million to Feinberg
Northwestern University Trustee Kimberly K. Querrey and the Louis Simpson Trust have made a new $100 million gift to the Feinberg School of Medicine to significantly expand the university’s biomedical research enterprise.
-
Preventing Maternal Mortality and Morbidity
The Supreme Court ruling in Dobbs v. Jackson Women’s Health Organization has created confusion for many women seeking medical care when pregnant. Nevertheless, Feinberg investigators continue to pursue research that identifies important factors that impact maternal health.
-
Improving the Care of Opioid Use Disorder and Pain
Sara Becker, PhD, director of IPHAM’s Center for Dissemination and Implementation Science, and C Hendricks Brown, PhD, professor of Psychiatry and of Behavioral Sciences, are principal investigators on a new $15.8 million center grant funded by the National Institute on Drug Abuse.
-
Krainc Elected to the National Academy of Medicine
Dimitri Krainc, MD, PhD, chair and Aaron Montgomery Ward Professor of Neurology, has been elected to the National Academy of Medicine.
-
Newly Identified Protein Drives Breast Cancer Stemness and Metastasis
Using machine learning, Northwestern scientists have demonstrated that the protein membrane CD81 interacts with CD44 in promoting tumor cell cluster formation and lung metastasis of triple negative breast cancer.
-
Novel Monoclonal Antibody Therapy for SARS-CoV-2
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
-
Center for Genetic Medicine Announces New Director for Transgenic and Targeted Mutagenesis Laboratory
Styliani (Stella) Markoulaki, PhD, has been named the new director of the Transgenic and Targeted Mutagenesis Laboratory.
-
Asian Americans’ Obesity Prevalence is not One-Size-Fits-All
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.
